Insulet Corp at Guggenheim Partners MedTech Disrupters Summit Transcript
Okay. And we're going to roll right into our next presentation. So coming to the stage now from Insulet is Doctor Trang Ly. Thank you very much for joining us.
So advance, and we also have release report [to be exact].
Okay, great. Just push that down, so they can see me.
Okay, great. Good morning, ladies and gentlemen, I'm Dr. Trang Ly. I'm Senior Vice President and Medical Director at Insulet. We're the makers of the Omnipod tubeless insulin pump. Before I joined Insulet, I was at Stanford University in clinical practice and research. My research focus was in closed-loop technologies, and I've been with the company for the last 2.5 years, and I lead the critical function at Insulet.
Can I just have the show of hands for people in the audience who either know someone or has Type 1 diabetes? Oh wow, that's actually a much higher percentage in -- of the audience than I was expecting. And I think that until you know or have lived with diabetes, it's very
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |